Unveiling novel 2-cyclopropyl-3-ethynyl-4-(4-fluorophenyl)quinolines as GPCR ligands via PI3-kinase/PAR-1 antagonism and platelet aggregation valuations; development of a new class of anticancer drugs with thrombolytic effects-Reference-Cited by-同舟云学术

Unveiling novel 2-cyclopropyl-3-ethynyl-4-(4-fluorophenyl)quinolines as GPCR ligands via PI3-kinase/PAR-1 antagonism and platelet aggregation valuations; development of a new class of anticancer drugs with thrombolytic effects

Published:2018-12 Issue: Volume:81 Page:468-480
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Thangarasu P.,Thamarai Selvi S.,Manikandan A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference70 articles.

1. Biological activities of quinoline derivatives;Kumar;Mini Rev. Med. Chem.,2009

2. Comprehensive review on current developments of quinoline-based anticancer agents;Shweta;Arabian J. Chem.,2016

3. Koorbanally NA1. A review on the synthesis and anti-cancer activity of 2-substituted quinolines;Gopaul;Anticancer Agents Med. Chem.,2015

4. A quinoline antibiotic from Rhodococcus erythropolis JCM 6824;Kitagawa;J. Antibiot. (Tokyo),2008

5. Inder Pal S, Kamlesh K.B. Synthesis and anti-HIV activity of alkylated quinoline 2,4-diols;Nafees;Bioorg. Med. Chem.,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imidazo[1,2‐α] azine's esters increase selectivity and anti‐inflammatory activity in microglial cells;Journal of Heterocyclic Chemistry;2024-03-21

2. EGFR Kinase Inhibiting Amino-enones for Breast Cancer; CADD Approach;Current Computer-Aided Drug Design;2024-01-30

3. Melanogenesis Inhibitory Activity, Chemical Components and Molecular Docking Studies of Prunus cerasoides Buch.-Ham. D. Don. Flowers;Journal of Evidence-Based Integrative Medicine;2023-01

4. Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach;Scientific Reports;2022-08-21

5. Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis;Frontiers in Microbiology;2022-05-06